DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Fleischhack G, Hasan C, Graf N, Mann G, Bode U.
IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial.
Br J Haematol 1998; 102: 647-655
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.